Q4 2023 Holdings
Filed 2024-02-14 | 52 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $188.1M | 3,201,440 | 9.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $175.3M | 2,100,000 | 8.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $124.9M | 3,421,541 | 6.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $122.7M | 4,279,464 | 6.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $103.3M | 1,726,000 | 5.1% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $90.2M | 500,000 | 4.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $89.3M | 6,448,359 | 4.5% |
| ImmunoGen Inc(IMGNEUR) | COM | 45253H101 | $87.8M | 2,961,000 | 4.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $82.4M | 1,120,192 | 4.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $81.2M | 8,198,642 | 4.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $79.1M | 250,000 | 3.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $78.4M | 2,202,812 | 3.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $62.7M | 650,000 | 3.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $60.9M | 160,000 | 3.0% |
| Merus N V | COM | N5749R100 | $52.3M | 1,900,000 | 2.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $43.9M | 1,466,051 | 2.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.1M | 1,000,000 | 2.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $39.2M | 1,676,733 | 2.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $36.1M | 600,000 | 1.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $31.8M | 400,000 | 1.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $30.6M | 1,602,200 | 1.5% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $27.8M | 1,300,000 | 1.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $27.6M | 600,000 | 1.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $25.1M | 608,614 | 1.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $24.2M | 665,000 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.2M | 1,650,000 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $20.0M | 1,819,132 | 1.0% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $19.8M | 1,804,058 | 1.0% |
| Day One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $17.4M | 1,189,943 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.3M | 400,000 | 0.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $15.9M | 1,732,571 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $11.4M | 1,400,000 | 0.6% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $11.0M | 2,568,287 | 0.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $10.1M | 1,121,327 | 0.5% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $9.5M | 1,440,000 | 0.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $8.9M | 646,058 | 0.4% |
| Third Harmonic Bio Inc(THRD) | COM | 88427A107 | $8.2M | 750,000 | 0.4% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $6.8M | 450,000 | 0.3% |
| Geron Corp(GERN) | COM | 374163103 | $6.3M | 3,000,000 | 0.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $5.4M | 250,000 | 0.3% |
| Orchestra Biomed Hldgs Inc(OBIO) | COM | 68572M106 | $2.2M | 238,193 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.9M | 500,000 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $1.8M | 600,000 | 0.1% |
| BioAtla Inc(BCAB) | COM | 09077B104 | $1.7M | 686,347 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $1.4M | 506,000 | 0.1% |
| Rain Oncology Inc | COM | 75082Q105 | $1.4M | 1,152,212 | 0.1% |
| Milestone Pharmaceuticals In(MIST) | COM | 59935V107 | $516.0K | 309,007 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $476.4K | 500,000 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $392.3K | 209,227 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $290.7K | 2,202,333 | 0.0% |